Bu öğeden alıntı yapmak, öğeye bağlanmak için bu tanımlayıcıyı kullanınız:
http://hdl.handle.net/11452/27062
Tüm üstveri kaydı
Dublin Core Alanı | Değer | Dil |
---|---|---|
dc.contributor.author | Ata, Barış | - |
dc.contributor.author | Seyhan, Ayşe | - |
dc.date.accessioned | 2022-06-10T13:08:12Z | - |
dc.date.available | 2022-06-10T13:08:12Z | - |
dc.date.issued | 2015-11 | - |
dc.identifier.citation | Seyhan, A. vd. (2015). "The impact of endometriosis and its treatment on ovarian reserve". Seminars in Reproductive Medicine, 33(6), 422-428. | en_US |
dc.identifier.issn | 1526-8004 | - |
dc.identifier.uri | https://doi.org/10.1055/s-0035-1567820 | - |
dc.identifier.uri | https://www.thieme-connect.de/products/ejournals/abstract/10.1055/s-0035-1567820 | - |
dc.identifier.uri | http://hdl.handle.net/11452/27062 | - |
dc.description.abstract | Endometriosis is a chronic disease mostly affecting women at reproductive age. There is a clear association between endometriosis and infertility; however, exact mechanisms are unknown. Some evidence suggests an adverse effect on oocytes. Endometriosis and its surgical treatment can affect quantitative ovarian reserve as well. In the presence of endometriomas, serum level of anti-Mullerian hormone (AMH) seems a more reliable marker of ovarian reserve than antral follicle count. Women with endometrioma have decreased serum AMH levels as compared with healthy controls. This is further declined after surgical excision, and the decline seems permanent. Bipolar cauterization of the ovary seems to be playing a role on ovarian damage. Extraovarian endometriosis and its surgical treatment can also be associated with decreased ovarian reserve, but there is limited information. Patients with endometriosis should be informed about fertility preservation options, especially in the presence of bilateral endometriomas or prior to surgery. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Thieme Medical | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | AFC | en_US |
dc.subject | AMH | en_US |
dc.subject | Endometrioma | en_US |
dc.subject | Endometriosis | en_US |
dc.subject | Ovarian reserve | en_US |
dc.subject | Surgery | en_US |
dc.subject | Anti-mullerian hormone | en_US |
dc.subject | Antral follicle count | en_US |
dc.subject | In-vitro fertilization | en_US |
dc.subject | Laparoscopic cystectomy | en_US |
dc.subject | Assisted reproduction | en_US |
dc.subject | Women | en_US |
dc.subject | Excision | en_US |
dc.subject | Pregnancy | en_US |
dc.subject | Coagulation | en_US |
dc.subject | Recurrence | en_US |
dc.subject | Obstetrics & gynecology | en_US |
dc.subject | Reproductive biology | en_US |
dc.subject.mesh | Anti-mullerian hormone | en_US |
dc.subject.mesh | Biomarkers | en_US |
dc.subject.mesh | Endometriosis | en_US |
dc.subject.mesh | Endometrium | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Fertility preservation | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Infertility, female | en_US |
dc.subject.mesh | Oocytes | en_US |
dc.subject.mesh | Ovarian reserve | en_US |
dc.subject.mesh | Ovary | en_US |
dc.subject.mesh | Ovulation | en_US |
dc.subject.mesh | Pregnancy | en_US |
dc.subject.mesh | Risk factors | en_US |
dc.title | The impact of endometriosis and its treatment on ovarian reserve | en_US |
dc.type | Article | en_US |
dc.identifier.wos | 000367179800009 | tr_TR |
dc.identifier.scopus | 2-s2.0-84951570242 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Kadın Hastalıkları ve Doğum Anabilim Dalı. | tr_TR |
dc.identifier.startpage | 422 | tr_TR |
dc.identifier.endpage | 428 | tr_TR |
dc.identifier.volume | 33 | tr_TR |
dc.identifier.issue | 6 | tr_TR |
dc.relation.journal | Seminars in Reproductive Medicine | en_US |
dc.contributor.buuauthor | Uncu, Gürkan | - |
dc.contributor.researcherid | AAT-3479-2021 | tr_TR |
dc.relation.collaboration | Yurt içi | tr_TR |
dc.relation.collaboration | Sanayi | tr_TR |
dc.identifier.pubmed | 26594869 | tr_TR |
dc.subject.wos | Obstetrics & gynecology | en_US |
dc.subject.wos | Reproductive biology | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.pubmed | PubMed | en_US |
dc.wos.quartile | Q2 (Obstetrics & gynecology) | en_US |
dc.wos.quartile | Q3 (Reproductive biology) | en_US |
dc.contributor.scopusid | 6603716169 | tr_TR |
dc.subject.scopus | Dienogest; Ovarian Reserve; Elagolix | en_US |
dc.subject.emtree | Muellerian inhibiting factor | en_US |
dc.subject.emtree | Biological marker | en_US |
dc.subject.emtree | Muellerian inhibiting factor | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Cauterization | en_US |
dc.subject.emtree | Endometriosis | en_US |
dc.subject.emtree | Endometrium tumor | en_US |
dc.subject.emtree | Fertility preservation | en_US |
dc.subject.emtree | Hormone blood level | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Oocyte | en_US |
dc.subject.emtree | Ovarian reserve | en_US |
dc.subject.emtree | Ovary follicle | en_US |
dc.subject.emtree | Surgical technique | en_US |
dc.subject.emtree | Treatment planning | en_US |
dc.subject.emtree | Blood | en_US |
dc.subject.emtree | Complication | en_US |
dc.subject.emtree | Endometriosis | en_US |
dc.subject.emtree | Endometrium | en_US |
dc.subject.emtree | Female | en_US |
dc.subject.emtree | Infertility, female | en_US |
dc.subject.emtree | Metabolism | en_US |
dc.subject.emtree | Ovary | en_US |
dc.subject.emtree | Ovulation | en_US |
dc.subject.emtree | Pathology | en_US |
dc.subject.emtree | Pathophysiology | en_US |
dc.subject.emtree | Pregnancy | en_US |
dc.subject.emtree | Risk factor | en_US |
Koleksiyonlarda Görünür: | Scopus Web of Science |
Bu öğenin dosyaları:
Bu öğeyle ilişkili dosya bulunmamaktadır.
DSpace'deki bütün öğeler, aksi belirtilmedikçe, tüm hakları saklı tutulmak şartıyla telif hakkı ile korunmaktadır.